STEPHEN P SQUINTO Insider Trading $ALXN ALEXION PHARMACEUTICALS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for STEPHEN P SQUINTO.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of STEPHEN P SQUINTO. STEPHEN P SQUINTO is EVP & Head of R&D in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP & Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP & Head of Research & Devel in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Chief Global Ops. Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Global Ops. Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Head of R&D in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Research & Development in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Research and Development in ALEXION PHARMACEUTICALS INC ($ALXN) and Exec VP & Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and Exec VP, Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and Exec. VP & Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and Executive VP in ALEXION PHARMACEUTICALS INC ($ALXN) and Executive VP& Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and Executive VP/Head of Research in ALEXION PHARMACEUTICALS INC ($ALXN) and Director in Chemomab Therapeutics Ltd. ($ANCN) and Director in Audentes Therapeutics, Inc. ($BOLD) and Director in SpringWorks Therapeutics, Inc. ($SWTX) and Head of Research and Dev in Passage BIO, Inc. ($PASG).

STEPHEN P SQUINTO in ALEXION PHARMACEUTICALS, INC.

Trading Symbol: ALXN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEPHEN P SQUINTO: EVP, Chief Global Ops. Officer, EVP, Global Ops. Officer, EVP, Head of R&D, EVP, Research & Development, EVP, Research and Development, EVP & Head of R&D, EVP & Head of Research & Devel, EVP & Head of Research, EVP, Head of Research, Executive VP& Head of
Holdings: 106,508 shares
Current Value: $13,603,202
Latest Transaction: Oct 28 2014
$ALXN Market Capitalization: $28.30B
$ALXN Previous Close: $127.72

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of STEPHEN P SQUINTO in ALEXION PHARMACEUTICALS, INC.

Sentiment: All, ALXN, BOLD, ANCN, PASG, SWTX

Page:   < prev 1 2 3

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 20 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP & Head of Resea ...SellS25.231002,52316,27616.4 K to 16.3 K (-0.61 %)
Dec 20 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP & Head of Resea ...SellS25.2440010,09616,37616.8 K to 16.4 K (-2.38 %)
Dec 20 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP & Head of Resea ...SellS25.2454013,63016,77617.3 K to 16.8 K (-3.12 %)
Dec 20 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP & Head of Resea ...SellS25.009,000225,00017,31626.3 K to 17.3 K (-34.20 %)
Dec 21 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...BuyJ0.00467012,34311.9 K to 12.3 K (+3.93 %)
Dec 20 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP & Head of Resea ...SellS25.001,81045,25026,31628.1 K to 26.3 K (-6.44 %)
Nov 19 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...Option ExerciseM2.3811,25026,7190
Nov 19 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...Option ExerciseM2.381,8754,4530
Nov 19 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...SellS20.7760012,46228,12628.7 K to 28.1 K (-2.09 %)
Nov 19 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...SellS20.751002,07528,72628.8 K to 28.7 K (-0.35 %)
Nov 19 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...SellS20.764118,53228,82629.2 K to 28.8 K (-1.41 %)
Nov 19 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...SellS20.7853311,07629,23729.8 K to 29.2 K (-1.79 %)
Nov 19 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...SellS20.9556711,87929,77030.3 K to 29.8 K (-1.87 %)
Nov 19 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...SellS20.904,34190,72730,33734.7 K to 30.3 K (-12.52 %)
Nov 19 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...SellS21.0065913,83934,67835.3 K to 34.7 K (-1.86 %)
Nov 19 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...SellS20.582755,66035,33735.6 K to 35.3 K (-0.77 %)
Nov 19 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...SellS20.592,02541,69535,61237.6 K to 35.6 K (-5.38 %)
Nov 19 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...SellS20.6358912,15137,63738.2 K to 37.6 K (-1.54 %)
Nov 19 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...SellS20.603,02562,31538,22641.3 K to 38.2 K (-7.33 %)
Nov 19 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...BuyM2.3811,25026,71941,25130 K to 41.3 K (+37.50 %)
Nov 19 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...BuyM2.381,8754,45330,00128.1 K to 30 K (+6.67 %)
Nov 18 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...Option ExerciseM2.383,1257,42213,125
Nov 18 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...Option ExerciseM2.381,8754,4530
Nov 18 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...SellS21.001,00021,00128,12629.1 K to 28.1 K (-3.43 %)
Nov 18 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...SellS20.823366,99629,12629.5 K to 29.1 K (-1.14 %)
Nov 18 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...SellS20.841,96440,93029,46231.4 K to 29.5 K (-6.25 %)
Nov 18 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...SellS21.171,70035,98931,42633.1 K to 31.4 K (-5.13 %)
Nov 18 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...BuyM2.383,1257,42233,12630 K to 33.1 K (+10.42 %)
Nov 18 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...BuyM2.381,8754,45330,00128.1 K to 30 K (+6.67 %)
Nov 15 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...GiftG0.001,200028,12629.3 K to 28.1 K (-4.09 %)
Nov 15 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...GiftG0.001,200029,32630.5 K to 29.3 K (-3.93 %)
Nov 15 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...GiftG0.001,200030,52631.7 K to 30.5 K (-3.78 %)
Oct 19 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...Option ExerciseM2.3818,12543,0471,875
Oct 19 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...SellS17.112,72546,62531,72634.5 K to 31.7 K (-7.91 %)
Oct 19 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...SellS17.504007,00034,45134.9 K to 34.5 K (-1.15 %)
Oct 19 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...SellS17.305,00086,50034,85139.9 K to 34.9 K (-12.55 %)
Oct 19 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...SellS17.264,60079,39639,85144.5 K to 39.9 K (-10.35 %)
Oct 19 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...SellS17.304006,92044,45144.9 K to 44.5 K (-0.89 %)
Oct 19 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...SellS16.701101,83744,85145 K to 44.9 K (-0.24 %)
Oct 19 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...SellS16.654,89081,41944,96149.9 K to 45 K (-9.81 %)
Oct 19 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PEVP, Head of Resear ...BuyM2.3818,12543,04749,85131.7 K to 49.9 K (+57.13 %)
Sep 16 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PExec VP & Head of R ...Option ExerciseM2.381,2502,9693,750
Sep 16 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PExec VP & Head of R ...Option ExerciseM2.386,87516,3280
Sep 16 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PExec VP & Head of R ...Option ExerciseM2.3810,00023,75020,000
Sep 16 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PExec VP & Head of R ...BuyM2.381,2502,96931,72630.5 K to 31.7 K (+4.10 %)
Sep 16 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PExec VP & Head of R ...BuyM2.386,87516,32830,47623.6 K to 30.5 K (+29.13 %)
Sep 16 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PExec VP & Head of R ...SellS17.505,00087,50023,60128.6 K to 23.6 K (-17.48 %)
Sep 16 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PExec VP & Head of R ...SellS17.755,00088,75028,60133.6 K to 28.6 K (-14.88 %)
Sep 16 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PExec VP & Head of R ...BuyM2.3810,00023,75033,60123.6 K to 33.6 K (+42.37 %)
Aug 18 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PExecutive VP& Head ...Option ExerciseM2.388,12519,29724,375
Aug 18 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PExecutive VP& Head ...Option ExerciseM2.3810,00023,75030,000
Aug 18 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PExecutive VP& Head ...BuyM2.388,12519,29723,60115.5 K to 23.6 K (+52.50 %)
Aug 18 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PExecutive VP& Head ...SellS15.3010,000153,00015,47625.5 K to 15.5 K (-39.25 %)
Aug 18 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PExecutive VP& Head ...BuyM2.3810,00023,75025,47615.5 K to 25.5 K (+64.62 %)
May 11 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PExecutive VP/Head o ...SellS21.015,000105,05015,47620.5 K to 15.5 K (-24.42 %)
Feb 25 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PExec VP & Head of R ...Option ExerciseA23.2910,000232,90010,000
Feb 10 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PExecutive VP/Head o ...SellS20.585,000102,87520,47625.5 K to 20.5 K (-19.63 %)
Feb 09 2004ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PExec VP, Head of Re ...BuyJ17.353996,92325,47625.1 K to 25.5 K (+1.59 %)
Dec 03 2003ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PExecutive VP/Head o ...SellS20.205,000101,00025,07730.1 K to 25.1 K (-16.62 %)
Nov 13 2003ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PExec. VP & Head of ...Option ExerciseA17.6712,000212,04012,000
Oct 03 2003ALXNALEXION PHARMACEUT ...SQUINTO STEPHEN PExecutive VPSellS20.015,000100,05030,07735.1 K to 30.1 K (-14.25 %)

Page:   < prev 1 2 3